Premium
External irradiation in the management of stage II endometrial carcinoma. A logical approach
Author(s) -
Gag James D.,
Moss William T.,
Gabourel Linda S.,
Stevens Kenneth R.
Publication year - 1979
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(197910)44:4<1247::aid-cncr2820440413>3.0.co;2-x
Subject(s) - medicine , stage (stratigraphy) , carcinoma , endometrial cancer , radium , complication , surgery , urology , nuclear medicine , cancer , paleontology , physics , nuclear physics , biology
Twenty‐nine patients with stage II endometrial carcinoma were reviewed and the possible risk factors involved in stage II disease are presented. Twenty‐four patients received external irradiation as part of their treatment with or without intracavitary or intravaginal radium and/or TAH BSO. The 5‐year actuarial survival in our series was 81.4%. The data showed that preoperative external irradiation can be effectively administered without undue complication. A strong argument against the traditional use of preoperative intracavitary radium is presented. Preoperative external irradiation administered with a 4‐field box technique to deliver a minimum dose of 5000 rad in 5–6 weeks to all of the structures at risk is the recommended treatment for stage II endometrial carcinoma.